Wockhardt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ADENOSINE USP, with a corresponding US DMF Number 20071.
Remarkably, this DMF maintains an Active status since its submission on May 15, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 01, 2015, and payment made on November 23, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II